Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Aisha Walker, PhD
Researcher Assistant Professor of Medicine
Division of Pulmonary,
Allergy and Critical Care Medicine
Vascular Medicine Institute
University of Pittsburgh
E1226-0A BST
200 Lothrop Street
Pittsburgh, Pennsylvania, United States
Dr. Walker is a Research Assistant Professor in the Vascular Medicine Institute at University of Pittsburgh. Dr. Walker is currently a Sickle Cell Scholar at Pitt. Her basic and translational research projects continue to investigate mechanisms related to pharmacologic therapies for sickle cell disease.
Dr. Walker’s primary research goal is to identify novel therapeutic strategies for the treatment of sickle cell disease (SCD). Her current projects are focused on identifying cellular and molecular modulators that mediate efficacy and toxicity of hydroxyurea, which is currently the only FDA approved drug for SCD. Dr. Walker’s work was the first to identify specific cell membrane transporters and microRNAs associated with the pharmacokinetics and clinical outcomes of hydroxyurea.
Related Content
-
High ED Utilization and Perceptions of Opioid Addictionhttps://www.youtube.com/watch?v=9xJ4VwtB...
-
Blood exchange transfusion safety for priapism in sickle cell disease: a single institution reviewBackground: Males with sickle cell disea...
-
Sickle Cell Disease – Hydroxyurea: What You Need to KnowIf you have sickle cell disease, your bo...
-
A multiple drug approach to preventing sickle cell crisisSickle cell disease is characterized by ...
-
Carolyn Rowley, PhDDr. Rowley is the Founder and Executive ...
-
Jo Howard, MB BChir, MRCP, FRCPathJo Howard, MB BChir, MRCP, FRCPath, beca...
-
New Research Suggests SANGUINATE™ Reduces the Number of Sickled Red Blood Cells in Patients with Vaso-Occlusive Cr...SANGUINATE™, the only investigational ...
+myBinder